Evidence map›Paper›PMID 38397774›Full record

ArticleAntioxidants (Basel, Switzerland)2024

Metformin Attenuates Neutrophil Recruitment through the H3K18 Lactylation/Reactive Oxygen Species Pathway in Zebrafish.

Ren Zhou, Rui-Chen Ding, Qian Yu, Cheng-Zeng Qiu, Hao-Yi Zhang, Zong-Jun Yin, Da-Long Ren

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ren ZhouCollege of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
Rui-Chen DingCollege of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
Qian YuCollege of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
Cheng-Zeng QiuCollege of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
Hao-Yi ZhangCollege of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
Zong-Jun YinCollege of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
Da-Long RenCollege of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
Anhui Agricultural University · CN

Funding

Anhui Provincial Natural Science Foundation 2208085Y10National Key Research and Development Program of China 2021YFD1301200
6 · The paper itself

Abstract

Beyond its well-established role in diabetes management, metformin has gained attention as a promising therapeutic for inflammation-related diseases, largely due to its antioxidant capabilities. However, the mechanistic underpinnings of this effect remain elusive. Using in vivo zebrafish models of inflammation, we explored the impact of metformin on neutrophil recruitment and the underlying mechanisms involved. Our data indicate that metformin reduces histone (H3K18) lactylation, leading to the decreased production of reactive oxygen species (ROS) and a muted neutrophil response to both caudal fin injury and otic vesicle inflammation. To investigate the precise mechanisms through which metformin modulates neutrophil migration via ROS and H3K18 lactylation, we meticulously established the correlation between metformin-induced suppression of H3K18 lactylation and ROS levels. Through supplementary experiments involving the restoration of lactate and ROS, our findings demonstrated that elevated levels of both lactate and ROS significantly promoted the inflammatory response in zebrafish. Collectively, our study illuminates previously unexplored avenues of metformin's antioxidant and anti-inflammatory actions through the downregulation of H3K18 lactylation and ROS production, highlighting the crucial role of epigenetic regulation in inflammation and pointing to metformin's potential in treating inflammation-associated conditions.

Indexed as

H3K18 lactylationmetforminneutrophil recruitmentROSzebrafish

Identifiers

PMID38397774
PMCPMC10886385
OpenAlexW4391348384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.